Search for: "Bayer Pharma A G"
Results 1 - 20
of 24
Sort by Relevance
|
Sort by Date
12 Jan 2022, 8:38 am
“In 2012, India’s first ever compulsory license was granted by the Indian Patent Office to Natco Pharma for generic production of Bayer Corp’s Nexaver® (Sorafenib Tosylate), a life-saving medicine used for treating liver and kidney cancer. [read post]
29 Jul 2021, 8:04 am
’” Bayer Pharma AG v. [read post]
7 Oct 2019, 11:12 am
IP Enforcement GuestKat Peter Ling, in‘There is No Such Thing as a Free Launch – CJEU Does Not Follow AG on Compensation for Wrongful PI' , reports and critically comments on the latest ruling in Bayer Pharma case C-688/17. [read post]
22 Oct 2015, 8:42 am
FDA beforeas the latest First Amendment follow-up action to Amarin Pharma, Inc. v. [read post]
19 Sep 2013, 9:53 am
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
15 Mar 2012, 10:40 am
G. [read post]
14 Mar 2012, 6:40 am
The patentee is Bayer Corporation, and the applicant for an compulsory license is Natco Pharma Limited, an Indian generic pharmaceuticals company. [read post]
22 Jun 2011, 4:09 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
10 Sep 2010, 1:21 am
Bayer AG, 05-2851-cv(L) Supreme Court, Nassau County Court Rejects Service on 11-Year Old in Foreclosure Action Citibank Trust Bank FSB v. [read post]
24 Feb 2010, 2:11 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
24 Feb 2010, 2:11 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
17 Feb 2010, 2:29 pm
Bayer Healthcare LLC, No. 1:10-cv-00001-SLR (D. [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider summary… [read post]
8 Dec 2008, 6:53 pm
Miller, Gérard Sicsic and John Wilkinson. [read post]
27 Sep 2008, 12:08 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
19 Aug 2008, 10:55 am
"As an expert who blogs occasionally," says security expert Kevin G. [read post]
16 Aug 2008, 2:43 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Belgium - eBay wins ruling against L’Oreal in dispute over liability for counterfeit goods sold in online auctions: (Managing Intellectual Property), (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert Jacobsen v… [read post]
23 May 2008, 1:03 am
: (Innovationpartners), ICANN reforms threaten voice of IP owners: (Managing Intellectual Property), INTA 130th annual meeting – a report: (IPKat), (Intellectual Property Watch), (IAM), INTA’s online Committee Portal premiers: (Managing Intellectual Property), Hans Van Bylen tells how careful brand management and exploitation of ‘glocal’ products helped Henkel become global player: (Managing Intellectual Property), Records number of IP owners applied for… [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’ still… [read post]
4 Apr 2008, 1:00 am
: (creativecommons.org), Neil Netanel’s copyright paradox: (Patry Copyright Blog), Isn’t it ironic: TechCrunch blames the music industry for the dangerous ideas of Lessig and the free culture movement: (IPcentral.com) CFP: First interdisciplinary research workshop on free culture: (creativecommons.org), Of limitations, exceptions and verse (WIPO copyright committee): (KEI) Pharma & Biotech Pharma & Biotech - General … [read post]
